Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of IGF-2 receptor agonist ligands for treatment of Angelman Syndrome and autism

Use of IGF-2 receptor agonist ligands for treatment of Angelman Syndrome and autism

US Patent 12083139 · Granted Sep 10, 2024

Estimated economic value: $495,147,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of mannose 6 phosphate and modifications thereof for memory enhancement and 2025
Use of mannose 6 phosphate and modifications thereof for memory enhancement and 2025
Use of mannose 6 phosphate and modifications thereof for memory enhancement and 2025
Photoreactive synthetic regulator of protein function and methods of use thereof2017
Photoreactive regulator of protein function and methods of use thereof2017
Photoreactive synthetic regulator of protein function and methods of use thereof2016
Photoreactive regulator of protein function and methods of use thereof2015
Photoreactive synthetic regulator of protein function and methods of use thereof2015
Photoreactive regulator of protein function and methods of use thereof2012
Photoreactive regulator of glutamate receptor function and methods of use thereo2012
Photoreactive regulator of protein function and methods of use thereof2012